Defining secondary progressive multiple sclerosis

J Lorscheider, K Buzzard, V Jokubaitis, T Spelman… - Brain, 2016 - academic.oup.com
A number of studies have been conducted with the onset of secondary progressive multiple
sclerosis as an inclusion criterion or an outcome of interest. However, a standardized …

Risk of secondary progressive multiple sclerosis: a longitudinal study

A Fambiatos, V Jokubaitis, D Horakova… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Background: The risk factors for conversion from relapsing-remitting to secondary
progressive multiple sclerosis remain highly contested. Objective: The aim of this study was …

Long-term disability progression in primary progressive multiple sclerosis: a 15-year study

MA Rocca, MP Sormani, M Rovaris, D Caputo… - Brain, 2017 - academic.oup.com
Prognostic markers of primary progressive multiple sclerosis evolution are needed. We
investigated the added value of magnetic resonance imaging measures of brain and …

Progressive multiple sclerosis

L Amezcua - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
PURPOSE OF REVIEW This article provides an update on progressive forms of multiple
sclerosis (MS) commonly referred to as primary progressive MS and secondary progressive …

Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis

JWL Brown, A Coles, D Horakova, E Havrdova… - Jama, 2019 - jamanetwork.com
Importance Within 2 decades of onset, 80% of untreated patients with relapsing-remitting
multiple sclerosis (MS) convert to a phase of irreversible disability accrual termed secondary …

Secondary progressive multiple sclerosis: current knowledge and future challenges

M Rovaris, C Confavreux, R Furlan, L Kappos… - The Lancet …, 2006 - thelancet.com
The secondary progressive phase of multiple sclerosis (MS), which is characterised by a
steady accrual of fixed disability after an initial relapsing remitting course, is not clearly …

Secondary progressive multiple sclerosis: a review of clinical characteristics, definition, prognostic tools, and disease-modifying therapies

T Ziemssen, V Bhan, J Chataway, T Chitnis… - Neurology …, 2022 - AAN Enterprises
Many challenges exist in the precise diagnosis and clinical management of secondary
progressive multiple sclerosis (SPMS) because of the lack of definitive clinical, imaging …

Secondary progressive multiple sclerosis: new insights

BAC Cree, DL Arnold, J Chataway, T Chitnis, RJ Fox… - Neurology, 2021 - AAN Enterprises
In most cases, multiple sclerosis (MS) begins with a relapsing-remitting course followed by
insidious disability worsening that is independent from clinically apparent relapses and is …

[HTML][HTML] Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study

G Bsteh, R Ehling, A Lutterotti, H Hegen, F Di Pauli… - PloS one, 2016 - journals.plos.org
Background Multiple sclerosis (MS) has a highly heterogenic course making prediction of
long term outcome very difficult. Objective The objective was to evaluate current and identify …

Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study

BG Weinshenker, M Issa, J Baskerville - Archives of neurology, 1996 - jamanetwork.com
Background: The anticipated rate of short-term worsening of disability scores is the basis of
power estimations in clinical trials of progressive multiple sclerosis (MS). While the clinician …